Conditions

Type 1 beta cells succumb to autoimmunity, leaving significantly reduced beta-cell mass and lifelong dependence on insulin replacement therapy, while type 2 beta cells fail to secrete sufficient insulin to overcome prevailing insulin resistance.

In a new international clinical trial, it was shown that the drug liraglutide 3.0 mg may reduce diabetes risk by 80% in individuals with obesity and prediabetes.

Valsartan associated with reduction in new onset diabetes in patients with impaired glucose tolerance

In part 2 of this Exclusive Interview, Blandine Lacroix shares the tools that Novo Nordisk provides to help practitioners as well as patients with the disease of obesity, including websites that share the science of obesity and weight loss.

Diagnosis of prediabetes for prevention of diabetes and diabetes-related complications.

Yoga proven to stimulate the organs to improve metabolic activities leading to efficient chemical transformations within a cell.

Study answers question of just how effective is a SGLT-2 inhibitor with metformin.

Prediabetes, previously undiagnosed diabetes patients interviewed.

Blandine Lacroix talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Blandine Lacroix explains the focus of Novo Nordisk on understanding how to improve the care of obesity in the search for the cure for diabetes.

Current study in Lancet showed that patients reduced their A1c levels by 1.55%.